Company Filing History:
3 out of 4,816 
1 out of 2 
1 out of 893 
Years Active: 2014-2021
Title: Anke Burger-Kentischer: Innovator in Immunomodulation
Introduction
Anke Burger-Kentischer is a prominent inventor based in Stuttgart, Germany. She has made significant contributions to the field of immunology, particularly through her innovative work on peptide agonists and antagonists. With a total of 4 patents, her research focuses on modulating immune responses to improve health outcomes.
Latest Patents
One of her latest patents involves peptide agonists and antagonists of TLR4 activation. This patent provides a group of peptides that can activate or inhibit toll-like receptor 4 (TLR4), which plays a crucial role in inflammatory signaling and host defense pathways. These peptides were derived in silico and tested in vitro in cell cultures. They hold potential for use in immunomodulatory compositions, such as vaccine adjuvants, and in pharmaceutical formulations aimed at modulating the innate immune system. Additionally, these peptides can be utilized in the preparation of TLR4 activators, TLR4 inhibitors, and MD2 labels for research purposes.
Another significant patent addresses toll-like receptor 9 antagonists. This patent outlines a method for preventing or treating diseases characterized by excessive immune responses. The method involves administering a composition that includes an active component, which may consist of various compounds or their pharmaceutically acceptable salts. This innovative approach aims to provide therapeutic solutions for individuals in need.
Career Highlights
Anke has worked with notable organizations, including the Fraunhofer Society for the Advancement of Applied Research and Pepticom Ltd. Her experience in these institutions has allowed her to advance her research and contribute to the scientific community.
Collaborations
Throughout her career, Anke has collaborated with esteemed colleagues such as Steffen Rupp and Amit Michaeli. These partnerships have enriched her work and fostered innovation in her field.
Conclusion
Anke Burger-Kentischer is a trailblazer in the realm of immunomodulation, with her patents paving the way for new therapeutic strategies. Her dedication to research and collaboration continues to impact the scientific community positively.